Standardized breast cancer mortality rate compared to the general female population of Iran
- PMID: 23317211
- DOI: 10.7314/apjcp.2012.13.11.5525
Standardized breast cancer mortality rate compared to the general female population of Iran
Abstract
Introduction: Breast cancer is the most common cancer in women. Improvements of early diagnosis modalities have led to longer survival rates. This study aimed to determine the 5, 10 and 15 year mortality rates of breast cancer patients compared to the normal female population.
Materials and methods: The follow up data of a cohort of 615 breast cancer patients referred to Iranian Breast Cancer Research Center (BCRC) from 1986 to 1996 was considered as reference breast cancer dataset. The dataset was divided into 5 year age groups and the 5, 10 and 15 year probability of death for each group was estimated. The annual mortality rate of Iranian women was obtained from the Death Registry system. Standardized mortality ratios (SMRs) of breast cancer patients were calculated using the ratio of the mortality rate in breast cancer patients over the general female population.
Results: The mean age of breast cancer patients at diagnosis time was 45.9 (±10.5) years ranging from 24-74. A total of 73, 32 and 2 deaths were recorded at 5, 10 and 15 years, respectively, after diagnosis. The SMRs for breast cancer patients at 5, 10 and 15 year intervals after diagnosis were 6.74 (95% CI, 5.5- 8.2), 6.55 (95%CI, 5-8.1) and 1.26 (95%CI, 0.65-2.9), respectively.
Conclusion: Results showed that the observed mortality rate of breast cancer patients after 15 years from diagnosis was very similar to expected rates in general female population. This finding would be useful for clinicians and health policy makers to adopt a beneficial strategy to improve breast cancer survival. Further follow-up time with larger sample size and a pooled analysis of survival rates of different centres may shed more light on mortality patterns of breast cancer.
Similar articles
-
Increased trend of breast cancer mortality in Iran.Asian Pac J Cancer Prev. 2012;13(1):367-70. doi: 10.7314/apjcp.2012.13.1.367. Asian Pac J Cancer Prev. 2012. PMID: 22502702
-
Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark.J Natl Cancer Inst. 2011 Sep 21;103(18):1363-72. doi: 10.1093/jnci/djr299. Epub 2011 Aug 31. J Natl Cancer Inst. 2011. PMID: 21881042
-
Burden of Breast Cancer in Iranian Women is Increasing.Asian Pac J Cancer Prev. 2015;16(12):5049-52. doi: 10.7314/apjcp.2015.16.12.5049. Asian Pac J Cancer Prev. 2015. PMID: 26163639
-
Relative Survival of Breast Cancer Patients in Iran.Asian Pac J Cancer Prev. 2015;16(14):5853-8. doi: 10.7314/apjcp.2015.16.14.5853. Asian Pac J Cancer Prev. 2015. PMID: 26320462
-
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035. Epidemiol Prev. 2016. PMID: 26951748
Cited by
-
OCT4, SOX2, and NANOG positive expression correlates with poor differentiation, advanced disease stages, and worse overall survival in HER2+ breast cancer patients.Onco Targets Ther. 2018 Nov 6;11:7873-7881. doi: 10.2147/OTT.S173522. eCollection 2018. Onco Targets Ther. 2018. PMID: 30464534 Free PMC article.
-
The Investigation of Risk Factors Impacting Breast Cancer in Guilan Province.Asian Pac J Cancer Prev. 2016 Oct 1;17(10):4623-4629. doi: 10.22034/apjcp.2016.17.10.4623. Asian Pac J Cancer Prev. 2016. PMID: 27892674 Free PMC article.
-
Comparison Cure Rate Models by DIC Criteria in Breast Cancer Data.Asian Pac J Cancer Prev. 2018 Jun 25;19(6):1601-1606. doi: 10.22034/APJCP.2018.19.6.1601. Asian Pac J Cancer Prev. 2018. PMID: 29936785 Free PMC article.
-
Adjuvant Trastuzumab Therapy for Early HER2-Positive Breast Cancer in Iran: A Cost-Effectiveness and Scenario Analysis for an Optimal Treatment Strategy.Pharmacoeconomics. 2018 Jan;36(1):91-103. doi: 10.1007/s40273-017-0557-6. Pharmacoeconomics. 2018. PMID: 28795341 Free PMC article.
-
Ethnic predisposition, risk factors and breast cancer presentation; a 10-year data. Single centered prospective cohort study from Karachi.Ann Med Surg (Lond). 2022 Sep 9;82:104612. doi: 10.1016/j.amsu.2022.104612. eCollection 2022 Oct. Ann Med Surg (Lond). 2022. PMID: 36268285 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical